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A phospholipas¢ A_,with an araehidonoyl residue preference was purified about I 1700.fold from hum,'m platelet soluble fraction to near homogenei- 
ty, The purified phospholipase A= exhibited a molecular mass of about 90 kDa on SD$ polyacrylamide g l electrophoresis and hydrolyzed phospho. 
lipids with an araehidonoyl residue more effectively than those with a Iinoleoyl residue, The catalytic activity of the purified enzyme detected with 
phosphatidylcholine as a substrate increased sharply between 3 × 10-' and 10 "n M free calcium ion, Thus, the 90-kDa phospholipasc A.. is consid. 
ered to be a novel enzyme, distinct from the 14.kDa one previously purified from human platelets, The 90.kDa phospholipase A~ may participate 
mainly in arachidonate metabolism of platelets, 
Phospholipas¢ Af, Human platelet; Calcium ion 
1, INTRODUCTION 
Intracellular phospholipase Az has attracted con- 
siderable attention because it may liberate from mem- 
brane phospholipids an arachidonoyl residue, which 
can subsequently be metabolized to various bioactive 
lipid mediators, such as prostaglandins, thromboxane 
and leukotrienes [1], The activation of phospholipase 
A2 has been suggested to represent a rate-limiting step 
in the whole process of lipid mediator synthesis, 
although the molecular basis of the regulatory 
mechanism is not fully understood at present [2]. We 
previously reported the detection in human platelet 
lysate of a phospholipase A~. activity which preferential- 
ly released an arachidonoyl residue [3]. From the acid 
extract of human platelet homogenate, Kramer et al. [4] 
have purified a 14-kDa phospholipase A2 whose pro- 
perties were not distinguishable from those of the 
human synovial fluid enzyme [5]. Thus, the acid- 
extractable phospholipase A2 activity detected in 
human platelet must be attributed to the 14-kDa group 
Abbrewations: GPC, glycerophosphocholine; GPE, glycerophospho- 
ethanolamine; PC, phosphatidyleholine; PE, phosphatidylethanol- 
amine. 
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II phospholipase A2 that exhibits no preference for an 
arachidonoyl residue [4,5] and would essentially func- 
tion in the extracellular space [6]. The present study was 
undertaken to purify human platelet phospholipase A2 
without acid treatment, The characteristics of the 
human platelet phospholipase A2 that most probably 
functions intracellularly are discussed. 
2. MATERIALS AND METHODS 
2. l. Preparation of enzyme source 
Platelet prepared for transfusion were used afler the expzration 
date, Washing and disruption of human platelets were performed as 
described previously [7]. Platelet lysate in TCB buffer (129 mM NaCh 
10.9 mM sodium citrate 8.9 mM NaHCO.~, 1 mg/ml dextrose, 10 mM 
Tris-HCl pH 7,2, 2,8 raM KCI, 0.8 mM KH,.PO4, 2 mM EGTA, 10 
mM mercaptoethanol) at a concentration f 5 x 109 celts/ml was ten- 
trifuged at 105 000 × ,g for 60 mix at 4°C; The resulting supernatant, 
with a protein concentration f about 14 mg/m], was stored at -80°C. 
2,2, Stcmdard assay for phospho/ipase A., 
l-Acyl-2-[ 1-"+C] arachidonoyl-glycerophosphocholine (-GPC) (59,0 
mCi/mmol), l-acyl-2-[14C]linoleoyl-GPC (58,5 mCi/mmol), 
l-acyl-2-[J+C]arachidonoyl-glyceropllosphoethanolamine (-GPE) 
(58,0 mCi/mmol), or l.acyl-2-[*4Cllinoleoyl.GPE (59,0 mCi/mmol) 
were purchased from the Radiochemical Centre, Amersham, UK and 
used as substrates. The standard incubation system (250/d) for the 
assay of phospholipase A2 contained 100 mM Tris-HCl (pH 9,0), 4 
mM CaCI,.,, 1 nag/ml bovine serum albumin and 0,5 nmol of radioac- 
tire substrate. The reaction was carried out at 37°C for 30 mix. The 
reaction was stopped by adding 1.25 ml of Dole's reagent and the 
radioactive free fatty acid released was extracted using the method 
described previously [8], 
2.3. Purification of phospholipase A2 
STEP 1. The soluble fraction of human platelet homogenates (100 
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ml) was loaded onto a 2.S x 20 ¢m DEAE;Sephacel column (Phar. 
macia, Sweden) pre-equilibrated In :tO mM TrIs.HCI pH '7,5 (burrer 
A) containins 150 m~ HaCi. The column was washed with burrer ^  
and elated with buffer A eomalnln~ 600 mM NaCl. 
STEP 2. The pooled phospholipase A= was loaded onto a 2,5 x 10 
cm Butyl.To:~opcarl column (Tosch, Tokyo) pre-equillbraled in bur'. 
rer A containing 600 mM NaCI. The column was washed thoroujthly 
with buffer A eontalninll 600 mM or 200 mM NaCI and then elated 
with buffer A. 
STEP 3. The pooled phospholipase A~ was loaded onto a "7 x 150 
mm I,.IA-1000 Hydroxyapafit¢ HPLC column (Tosoh, Tokyo) In 10 
mM sodium phosphate buffer (pH 7,4). The protein was eluted with 
a linear gradient from 10 mM to 250 raM sodium ~hosphat¢. buffer, 
STEP 4. The active t'raetion was concentrated using a Centrlcon 10 
(Amicon, USA) and loaded onto a Superos¢ 12 CPharmacia, Sweden) 
HPLC coluran. The protein was elated with buffer A contaiains IS0 
ram NaCI. 
3. RESULTS 
3,1. Purification of an arachidonoyl.preferential 
phospholipase A2 
Using l-acyl-2-[t4C]arachidonoyl-GPC as a 
substrate, the human platelet soluble plaospholipase A2 
was purified by sequential use of column 
cl l romatographies on DEAE-Sephacel,  Buty l -  
Toyopear l ,  HA-1000 Hydroxyapaf i te  (HPLC) ,  and 
Superose 12 (HPLC)  (Fig. 1), In the appropriate frac- 
tions from each column chromatography,  essentially a
single peak with phospholipase A2 activity was 
observed, 
The specific activity of  the final preparation was 259 
nmol /min /mg protein and, starting from the soluble 
fraction of human platelet homogcnates, the purifica- 
tion achieved was about I 1700.fold (Table I). These are 
the highest values so far reported for platelet non,group 
lI phosphol ipase Aa [9-11]. The  yield was 4.1070. The 
final preparation yielded a single protein band on SDS 
polyacrylamide gel electrophoresis with a molecular 
mass of  about 90 kDa (Fig. 2A), The appearance of tile 
90.kDa protein band in eacl~ fraction from the Su perose 
gel fi ltration column paralleled that of the enzymatic 
activity (Fig~ ID and 2B). Addition of mercaptoethanol 
did not change the apparent molecular mass (data nol 
shown). Thus,  the purifed phospholipase A2 consisted 
of a single polypeptide with a molecular mass of about 
90 kDa. 
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Fig. 1. Elution profiles of protein ( ) and phospholipase A2activity tO) from DEAE Sel0hacel column chromatography (A), Butyl-Toyopearl 
hydrophobic chromatography (B), HA-1000 Hydroxyapatite HPLC (C), and Superose !2 gel filtration HPLC (D). Flow rate: 10 ral/h (A and B), 
0.5 ral/rain (C), 0.3 ml/min (D). Fraction volume: 6ml (A), 3 ml (B), 0.5 ml (C), 0.3 ml (D). Aliquots used for plmspholipase A2assay: 10 #l 
(A and B), 3 ~tl (C), I p.l (D). 
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Table I 
Summary of llte puril'h:alton or pho~ph01ipas¢ A= from human plal¢l¢l .+olubl¢ I'ra,~Om 
Step Prolein Total ¢t<livily Specific activity. Yield Pttrifleaiion . . . . . .  
trot+} (prnol++min) (pmol/min. m=) 0v=} (fold} 
100 000 ~ X sup~rnatant 1400 31 ;~t2 22 100 I 
DEAE.SepI~aeel ~7.7 ;aS 47'0 666 121 ~t~. 
flulyI-Toyopearl 1.37 18.1212 1.1 )81 Jll 660 
Hydroxyapattte 0.0It 3 657 4~ T21 I 1,6 2 0~llt 
Superose 12 0,00~ 1 29,~ 2~9 (RI0 4. I I I 700 
3.2, Enzymatic properties 
When assayed using l-acyl-2,[ l -~'~C]arachidonoyl - 
GPC as a substrate, the 90-kDa phosphol ipase A= was 
sensitive to a micromolar  concentrat ion o f  calc ium ions 
(Fig, 3); an addit ion or" 2 mM EGTA inhibited the 
hydro lyz ing activity. No appreciable activity was 
observed at 3 x 10,  7 M free calcium concentrat ion,  
and the activity increased sharply as tlie free calc ium 
concentrat ion  was increased f rom 3 × 10" 7 to 10-  6 M. 
At 10 -6 M, almost full activity was observed. A similar 
ca lc ium ion requirement was observed when 
I -acy l -2 - [ l - t4C]arach idonoyl -GPE was hydrolyzed by 
A 
~200kDa 
the 90-kDa phospho l ipase  A= (data not  shown) .  I t  
should be noted that the human 14-kDa group II 
phosphol ipase A2 required a higher concent rat ion  o f  
calc ium ions for tile max imum activity [5], 
The purif ied 90-kDa phosphol ipase Aa hydro lyzed 
l -acy l -2 - [ l )4C]arach idonoy l .GPC more effectively 
than l -acyi -2-[ l -14C] l inoleoyl .GPC (Fig. 4A), A similar 
fatty acid preference was also observed when phos,  
phat idy lethano lamine (PIE) was used as a substrate (Fig. 
4B). The human 14-kDa group  lI phosphol ipase A2 did 
not  exhibit such a fatty acid preference [5]. 
Exposure o f  tile purif ied 90-kDa phosphol ipase A-~ to 
B 
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Fig. 2. SDS-polyacrylamide (1007~) gel electrophoresis of the purified phospholipase A2(A) or of each fraction from Superose 12 HPLC (B). A. 
Lane a contains purified phospholi pase A2 (about 100 ng as protein). Laneb contains marker proteins: rabbit muscle myosin (molecular mass 200 
kDa), E. colt (3-galactosidase (116 kDa). rabbit muscle phosphorylase B (97 kDa), bovine serum albumin (67 kDa) and egg albumin (45 kDa). B. 
10 ~d of each fraction was applied. 
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Fig. 3, Effect of calcium iont on the purified human platelet 
phospholipase A:. The purified enzyme (6 na) was incubated with 0,5 
nmol of l-acyl-2.l.='~C]arachidonoyl.CPC in 100 mM Tri~-HCI (pH 
7;4) containing 2 mM ECTA anti various concentrations f CaCI= in 
a total volume of 250 ~1 for 15 rain at 37"C, The absolute eoncentra. 
finn of free calcium was calculated as described [22], Results arc 
shown as means of three separale experiments. 
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Fig, 4, Substrate specificity of purified human platelet phospholipase 
An. Activity was assayed with indicated amounts of purified enzyme 
under standard assay conditions except hat a nmol o f  radioactive 
substrate was used. A 1-acyl-2-[l-14C]arachidonoyl-GPC ($),
l-acyl-2-[IJ4Cllinoleoyl-GPC (©). B, l-acyl-2-[1-~4C]arachidonoyl . 
GPE (t),  l-acyl-2.[IJ4C]linoleoyl-GPE (©), 
acidic conditions caused irreversible loss of the activity; 
when incubated in 100 mM glycine-HCl buffer (pH 2) 
for 60 rain at 4°C, neutralized, and then assayed, no en- 
zymatic activity was detected. 
4. DISCUSSION 
From the soluble fraction of human platelet 
homogenates, we purified a phospholipase A2 with a 
molecular mass o f  about 90 kDa. It catalyxes the release 
of an arachidonoyl residue from the sn-2 position of 
phosphatidylcholine (PC) and PE more effectively than 
that of a linoleoyi residue, The catalytic activity of the 
purified 90.kDa enxyme increased sharply between 3 x 
[O ~ anti l0 "a M calciam ions, This calcium ion 
dependence roushly ~:orresponds to the increase in tree 
calcium ions induced upon stimulation of platelets [ I2], 
These observations may indicate that the  90-kDa 
phospholipase A2 participates in the stimulus- 
dependent release or arachidonate from either PC or 
PE. 
Several investigators have detected and partially 
purified a phosph~lipase A= activity in acid.extracted 
fraction of  human platelets [13,14], In 1988, Kramer et 
al. [4] purified this acid-stable human platelet enzyme 
and found its molecular mass to be about 14 kDa, They 
concluded that its properties resembled those of the 
phospholipase Aa purified from synovia[ fluid of pa- 
tients with rheumatoid arthritis, suggesting that their 
enzyme can most probably be categorized as a mam- 
malian group It phospholipase A2. Antibodies raised 
against rat platelet secretory [15] and human synovial 
fluid [16] phospholipases Az, both of  which belong to 
the class of mammalian group II phospholipase A2, 
failed to neutralize the purified 90,kDa phospholipase 
Az activity (data not shown). Thus, the 90-kDa enzyme 
distinctly differed from the mammalian group II en- 
zyme. The findings that the purified 90.kDa 
phospholipase A2 was labile under the acidic condition 
and that it exhibited a unique fatty acid preferen¢ : and 
a high sensitivity to free calcium 1on further strengthen- 
ed this conclusion. 
Besides the acid-extractable enzyme, the existence m 
human platelets of another type of phospholipase Az 
has been suggested by several authors [4,9,10,17,18]. 
For instance, a deoxycholate-solubilized activity was 
detected in human platelet homogenates which were 
prepared at neutral pH [9,10]. Judging from the 
subcellular distribution, the present 90-kDa enzyme 
with an arachidonoyl-residue pr ference would corre- 
spond to that activity. 
We recently purified the 88-kDa phospholipase A2 
from rabbit platelet cytosolic fraction [19]. The human 
90-kDa and rabbit 88-kDa enzymes exhibited very 
similar properties to each other. Like rat platelets [8], 
rabbit platelets contain a secretory 14-kDa group II 
phospholipase A2 [20]. Since the group II 
phospholipase A2 present in rabbit platelets is 
measurable without acid treatment, we previously 
detected two distinct phospholipase A2 activities in the 
soluble fraction of rabbit platelets [21]. The data ac- 
cumulated so far and discussed in part above are consis- 
tent with the conclusion that human plate!ets also bear 
at least two distinct phospholipase Az; i.e. a secretory 
14-kDa group II and intracellular 90-kDa ones. Indeed, 
when the human platelet homogenate was extracted 
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with an acidic ~olutlon, the pho~phollpa~e A= actlvl|y 
observed w~,~ completely neutralized with tintl-hum~n 
~ynovial fluid antibod y. indlcatin~ thai tt wa~ due to the 
m~tmmali~ln Broup I! enzyme (to be published). !| 
should, however, be emphasized that no additional 
phospholipase Aa activity was found durlnl~ purific~- 
lion of  the 90-kDa enzyme, su88e~tin~ that th~ human 
14.kD~ llroup l I  enzyme activity present in ~i crude 
platei©t homolltna~e could not be detected under ~he 
conditions employed here, Some inhibitory factor(s) 
that is labile under acidic conditions mioht have 
prevented us from detectinl~ it, 
Atk#mwltdXemtnt~: Thi~ work w=t~ upporled hi parl by' Elf=mrs-In, 
aid for $¢ienlifl¢ Rtlettt~ll (NO~, 63480490 .and O~.;~Y/OgO] from Ilia 
Ministry of Edu~.ali~fl, $¢t¢ne¢ and Culture of J~ipan. 
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